Dashboard
Manage Tickers

IRMD IRADIMED CORP

Nasdaq iradimed.com


$ 76.29 $ 2.90 (3.96 %)    

Thursday, 16-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 597.69 $ -2.23 (-0.37 %)
DIA $ 458.55 $ -3.15 (-0.68 %)
SPY $ 658.43 $ -4.53 (-0.68 %)
TLT $ 91.43 $ 0.68 (0.75 %)
GLD $ 402.00 $ 9.06 (2.34 %)
$ 76.05
$ 73.69
$ 72.11 x 15
$ 78.50 x 2
$ 73.10 - $ 76.59
$ 46.33 - $ 78.38
63,437
na
966.98M
$ 0.72
$ 46.81
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2025 06-30-2025 10-Q
2 05-05-2025 03-31-2025 10-Q
3 03-06-2025 01-01-1970 10-K
4 10-31-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 03-01-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-02-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 03-04-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 03-05-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-06-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 03-07-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-06-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 03-10-2017 12-31-2016 10-K
36 11-04-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 03-10-2016 12-31-2015 10-K
40 11-10-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

iradimed-raises-fy2025-gaap-eps-guidance-from-155-165-to-160-170-vs-159-est
iRadimed Raises FY2025 GAAP EPS Guidance f...
08/01/2025 12:36:00

iradimed-raises-fy2025-adj-eps-guidance-from-171-181-to-176-186-vs-174-est-raises-fy2025-sales-guidance-from-7800m-8200m-to-8000m-8250m-vs-7943m-est
iRadimed Raises FY2025 Adj EPS Guidance fr...
08/01/2025 12:35:29

iradimed-sees-q3-gaap-eps-041-045-vs-040-est
iRadimed Sees Q3 GAAP EPS $0.41-$0.45 vs $...
08/01/2025 12:34:33

iradimed-sees-q3-adj-eps-045-049-vs-043-est-sees-sales-20500m-20900m-vs-1975m-est
iRadimed Sees Q3 Adj EPS $0.45-$0.49 vs $0...
08/01/2025 12:33:42

iradimed-q2-adj-eps-049-beats-043-estimate-sales-2041m-beat-2001m-estimate
iRadimed Q2 Adj. EPS $0.49 Beats $0.43 Est...
08/01/2025 12:31:32

Core News & Articles
Earnings Scheduled For August 1, 2025
08/01/2025 08:32:17

earnings-preview-iradimed
Earnings Preview: iRadimed
07/31/2025 18:02:49

iradimed-sees-q2-adj-eps-041-044-vs-043-est-sees-sales-19700m-19900m-vs-1981m-est
iRadimed Sees Q2 Adj EPS $0.41-$0.44 vs $0...
05/05/2025 11:09:44

iRadimed (NASDAQ:IRMD) is looking for Q2 Adj EPS of $0.41-$0.44 vs $0.43 analyst estimate. sees sales of $19.700 million-$19.90...

iradimed-affirms-fy2025-gaap-eps-guidance-of-155-165-vs-164-est
iRadimed Affirms FY2025 GAAP EPS Guidance ...
05/05/2025 11:09:32

iRadimed (NASDAQ:IRMD) affirms FY2025 GAAP EPS guidance from $1.55-$1.65 to $1.55-$1.65 vs $1.64 analyst estimate..

iradimed-sees-q2-gaap-eps-037-040-vs-041-est
iRadimed Sees Q2 GAAP EPS $0.37-$0.40 vs $...
05/05/2025 11:09:23

iRadimed (NASDAQ:IRMD) is looking for Q2 GAAP EPS of $0.37-$0.40 vs $0.41 analyst estimate..

iradimed-affirms-fy2025-adj-eps-guidance-of-171-181-vs-175-est-affirms-fy2025-sales-guidance-of-7800m-8200m-vs-7941m-est
iRadimed Affirms FY2025 Adj EPS Guidance o...
05/05/2025 11:09:12

iRadimed (NASDAQ:IRMD) affirms FY2025 Adj EPS guidance from $1.71-$1.81 to $1.71-$1.81 vs $1.75 analyst estimate. Affirms FY202...

iradimed-q1-adj-eps-042-beats-041-estimate-sales-1951m-beat-1933m-estimate
iRadimed Q1 Adj. EPS $0.42 Beats $0.41 Est...
05/05/2025 11:02:22

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.41 by 2.4...

Core News & Articles
Earnings Scheduled For May 5, 2025
05/05/2025 08:32:22

roth-mkm-reiterates-buy-on-iradimed-raises-price-target-to-72
Roth MKM Reiterates Buy on iRadimed, Raise...
02/14/2025 18:04:26

Roth MKM analyst Jason Wittes reiterates iRadimed (NASDAQ:IRMD) with a Buy and raises the price target from $60 to $72.

iradimed-expects-2025-revenue-of-78m-82m-versus-consensus-of-8066m-with-adjusted-eps-of-171-181-versus-consensus-of-175
Iradimed Expects 2025 Revenue Of $78M-$82M...
02/13/2025 13:38:03

iradimed-expects-q1-2025-revenue-of-192m-194m-versus-consensus-of-1913m-with-adjusted-eps-of-039-043-versus-consensus-of-041
Iradimed Expects Q1 2025 Revenue Of $19.2M...
02/13/2025 13:37:33

iradimed-q4-2024-adj-eps-044-inline-sales-1939m-beat-1914m-estimate
iRadimed Q4 2024 Adj EPS $0.44, Inline, Sa...
02/13/2025 13:31:42

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.44 per share which met the analyst consensus estimate. This is a 12.82...

earnings-scheduled-for-february-13-2025
Earnings Scheduled For February 13, 2025
02/13/2025 08:32:25

iradimed-reports-prelim-q4-revenue-192m-194m-prelim-fy24-revenue-731m-733m
IRADIMED Reports Prelim. Q4 Revenue $19.2M...
01/10/2025 13:45:48

iradimed-raised-fy24-adj-eps-to-164--167-from-152--162-vs-156-est-revenue-to-727m-731m-from-72m-74m-vs-7262m-est
IRadimed Raised FY24 Adj EPS To $1.64 -$1....
10/31/2024 12:23:33

For the full year of 2024, the Company expects to report revenue of $72.7 million to $73.1 million, GAAP diluted earnings per s...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION